167 related articles for article (PubMed ID: 11358150)
41. Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteome.
Bhattacharya D; Saha S; Basu S; Chakravarty S; Chakravarty A; Banerjee D; Chakrabarti A
Proteomics Clin Appl; 2010 May; 4(5):480-8. PubMed ID: 21137065
[TBL] [Abstract][Full Text] [Related]
42. Rat brain proteins: two-dimensional protein database and variations in the expression level.
Fountoulakis M; Schuller E; Hardmeier R; Berndt P; Lubec G
Electrophoresis; 1999 Dec; 20(18):3572-9. PubMed ID: 10612283
[TBL] [Abstract][Full Text] [Related]
43. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Seidl R; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():315-22. PubMed ID: 10666686
[TBL] [Abstract][Full Text] [Related]
44. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.
Cheon MS; Bajo M; Gulesserian T; Cairns N; Lubec G
Electrophoresis; 2001 Feb; 22(3):445-8. PubMed ID: 11258753
[TBL] [Abstract][Full Text] [Related]
45. Comparative 2D-electrophoretic mapping of human and rodent hepatic stress proteins as potential biomarkers.
Witzmann FA; Fultz C; Lipscomb J
Appl Theor Electrophor; 1995; 5(2):113-7. PubMed ID: 8573598
[TBL] [Abstract][Full Text] [Related]
46. Identification of stress proteins in endothelial cells.
Portig I; Pankuweit S; Lottspeich F; Maisch B
Electrophoresis; 1996 Apr; 17(4):803-8. PubMed ID: 8738348
[TBL] [Abstract][Full Text] [Related]
47. Hsp and chaperone distribution during endochondral bone development in mouse embryo.
Loones MT; Morange M
Cell Stress Chaperones; 1998 Dec; 3(4):237-44. PubMed ID: 9880236
[TBL] [Abstract][Full Text] [Related]
48. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
[TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.
Gulesserian T; Kim SH; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2002 Feb; 291(1):62-7. PubMed ID: 11829462
[TBL] [Abstract][Full Text] [Related]
50. Cognitive enhancement by SGS742 in OF1 mice is linked to specific hippocampal protein expression.
Sunyer B; Diao WF; Kang SU; An G; Boddul S; Lubec G
J Proteome Res; 2008 Dec; 7(12):5237-53. PubMed ID: 19367722
[TBL] [Abstract][Full Text] [Related]
51. Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.
Engidawork E; Balic N; Juranville JF; Fountoulakis M; Dierssen M; Lubec G
J Neural Transm Suppl; 2001; (61):149-62. PubMed ID: 11771740
[TBL] [Abstract][Full Text] [Related]
52. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells.
Vercoutter-Edouart AS; Czeszak X; Crépin M; Lemoine J; Boilly B; Le Bourhis X; Peyrat JP; Hondermarck H
Exp Cell Res; 2001 Jan; 262(1):59-68. PubMed ID: 11120605
[TBL] [Abstract][Full Text] [Related]
53. Plasmodium berghei proteome changes in response to SSJ-183 treatment.
Lu J; Arai C; Md AB; Ihara M
Bioorg Med Chem; 2011 Jul; 19(13):4144-7. PubMed ID: 21622001
[TBL] [Abstract][Full Text] [Related]
54. Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease.
Cheon MS; Fountoulakis M; Cairns NJ; Dierssen M; Herkner K; Lubec G
J Neural Transm Suppl; 2001; (61):281-8. PubMed ID: 11771751
[TBL] [Abstract][Full Text] [Related]
55. Differences in protein level between neonatal and adult brain.
Fountoulakis M; Hardmaier R; Schuller E; Lubec G
Electrophoresis; 2000 Feb; 21(3):673-8. PubMed ID: 10726776
[TBL] [Abstract][Full Text] [Related]
56. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid.
Perluigi M; di Domenico F; Fiorini A; Cocciolo A; Giorgi A; Foppoli C; Butterfield DA; Giorlandino M; Giorlandino C; Schininà ME; Coccia R
Proteomics Clin Appl; 2011 Apr; 5(3-4):167-78. PubMed ID: 21360684
[TBL] [Abstract][Full Text] [Related]
57. Changes in the brain protein levels following administration of kainic acid.
Krapfenbauer K; Berger M; Lubec G; Fountoulakis M
Electrophoresis; 2001 Jun; 22(10):2086-91. PubMed ID: 11465509
[TBL] [Abstract][Full Text] [Related]
58. Expression profiles of proteins in fetal brain with Down syndrome.
Cheon MS; Fountoulakis M; Dierssen M; Ferreres JC; Lubec G
J Neural Transm Suppl; 2001; (61):311-9. PubMed ID: 11771754
[TBL] [Abstract][Full Text] [Related]
59. Comparative proteomic profiling of murine skin.
Huang CM; Foster KW; DeSilva T; Zhang J; Shi Z; Yusuf N; Van Kampen KR; Elmets CA; Tang DC
J Invest Dermatol; 2003 Jul; 121(1):51-64. PubMed ID: 12839563
[TBL] [Abstract][Full Text] [Related]
60. Derangement of hypothetical proteins in fetal Down's syndrome brain.
Shin JH; Gulesserian T; Weitzdoerfer R; Fountoulakis M; Lubec G
Neurochem Res; 2004 Jun; 29(6):1307-16. PubMed ID: 15176487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
